There is a wide range of rehabilitation protocols after knee arthroscopic procedures, mainly based on specialist exercises. They comprise of specific stages and key moments but should also be individualized and adjusted to the patient’s needs.
OBJECTIVE:
The aim of the study was to evaluate the BodyFlow device impact on physical and psychological functioning of the subjects after knee arthroscopy.
METHODS:
Ninety three patients were randomly divided into the study and control group. Each study group subject performed mild electrostimulation using the BodyFlow device for three weeks, five times a day for 20 minutes along with the standard rehabilitation protocol. Control group subjects were treated according to the standard rehabilitation protocol after knee arthroscopy. Healthy and operated lower limb size, a range of the knee joint motion, and the flexor and extensor strength were measured 3, 6, and 9 weeks after arthroscopy. At each measurement, the SF-36 and KOOS surveys were collected.
RESULTS:
On study day 21, a positive, statistically significant, difference in the knee joint size, range of flection and extension, flexor and extensor strength as well as all KOOS survey subscales and physical functioning categories included in the SF-36 survey was observed. On study day 63, positive effects persisted and significant differences in other categories included in the SF-36 survey were observed.
CONCLUSION:
Application of mild electrostimulation using the BodyFlow device has a positive impact on the swelling in the knee joint region, range of motion, extensor and flexor strength as well as physical, psychological, and social functioning.
Knee arthroscopy is one of the most common surgical interventions and is characterized by a low risk of complications [1]. Accompanying partial meniscectomy is most frequently performed in middle-aged individuals suffering from persistent knee pain [2]. On the other hand, arthroscopic reconstruction of the anterior cruciate ligament concerns athletes who do contact sports, where knee injuries with the ACL tearing occur most frequently [3, 4]. Problems impacting subjects after knee arthroscopy primarily include pain and related deterioration of everyday functioning and mental state [5, 6]. Other ailments include swelling, limited range of the knee motion and muscle atrophy affecting particularly quadriceps femoris [7, 8]. Rehabilitation, especially after the anterior cruciate ligament reconstruction is of critical importance [9, 10]. There is a wide range of postoperative protocols but they are all based on specialist exercises, comprise of specific stages and include key moments but should always be individualized and adjusted to the subject’s needs [11].
Postoperative rehabilitation procedure that primarily includes kinesiotherapy oftentimes involves physical therapy, especially electrotherapy [12, 13, 14, 15]. One of the treatments supplementing rehabilitation after knee arthroscopy is BodyFlow. The first treatise described the impact of Bodyflow application on the blood flow, fibrinolysis, and activation of anticoagulant factors [16] and the second one focused on its impact on healthy subjects after physical effort [17]. Henceforth, two other scientific works including findings on the BodyFlow application were published: One was published in 2010 and focused on its impact on lymphedema [18], while the other one was published in 2014 and discussed the impact of mild electrostimulation on the healing of wounds caused by the lower leg ulceration [19]. Given the short period of time and the fact that this is an innovative treatment, the number of studies published in peer-reviewed journals is small. The manufacturer recommends its application after knee arthroscopy, but, unfortunately, no studies on the efficacy of mild electrostimulation using BodyFlow after such interventions are available in the literature.
Flowchart of the study.
The research question in our study was thus as follows: Does mild electrostimulation using the Body Flow device have an impact on the knee functioning and convalescence of subjects after arthroscopy?
Methods
All subjects were randomly assigned to the study or control group prior to the study. Study group subjects were treated according to a generally adopted scheme of rehabilitation procedure after knee arthroscopy and received devices for mild electrostimulation (BodyFlow Portable P2CH) to use independently for 3 weeks. The control group subjects were treated according to the generally adopted standards applied after knee arthroscopy. Randomization was performed by deployment of all subjects from one orthopedic center to the study group, while the subjects from another center were assigned to the control group. The measurements were taken 3 and 6 weeks after arthroscopy (study group subjects returned devices) and 9 weeks after arthroscopy, by a person who knew how the subjects were deployed (Fig. 1).
All consecutive patients who were operated at two orthopedics centers with knee arthroscopy (meniscectomy or reconstruction of the anterior cruciate ligament) were qualified for the study. Patients with implanted cardiological devices, history of systemic disorders, deep vein thrombosis, fractures of the involved limbs, neoplastic disease, and suspected pregnancy were excluded.
Study group subjects were given the BodyFlow Portable P2CH device for mild electrostimulation so that they were able to perform treatments on their own for 21 days (from day 21 to 42). The treatments were performed five times a day, every three hours. A local (sectional) 4-electrode stimulation was applied using flat, adhesive, rubber, 5 cm 9 cm electrodes (placed 10 cm from the knee slit proximally and distally) where two circuits covered the knee after arthroscopy (Fig. 2). The standard program was applied: it was 20-minute long and amperage ranged between 1 and 40 mA depending on the patient’s feelings. The pulses generated during treatments were monophasic, triangular, 6 ms long, 500 ms – long break, frequency 1.5 Hz and cyclically repeated variable polarization of stimulating pulses occurred. Both groups were instructed about the future procedure according to the generally adopted schemes, including unweighting and weighting of the operated limb.
Location of the electrodes during therapy (own material).
The preliminary assessment was conducted to confirm or exclude the possibility of participating in the study. After a preliminary assessment had been made, symmetrical measurements of both lower limbs, knee motion range and knee extensor and flexor strength according to Lovett were taken. Moreover, subjects responded to the KOOS and SF-36 surveys. All measurements were collected at the time of surgery 3.6 and 9 weeks postoperatively.
Size measurements were taken by means of the tape, in the supine position, symmetrically, beginning from a healthy lower limb. Four measurements were taken on each limb, according to the methodology of measurements of the lower limb size – the first thigh measurement (taken around the largest part of upper leg), the second thigh measurement (6 cm from the upper pole of the knee cap), the knee measurement (through the knee joint cleft) and the first shank measurement (around the largest part of calf).
Measurements of the range of motion – knee flexion and extensions – were taken by means of the goniometer, symmetrically, beginning from a healthy limb, in the prone position, with feet placed beyond the couch and stabilized pelvis. The goniometer axis (corresponding to the crosswise axis of the knee) was located in the vicinity of the fibular head, a fixed arm was directed at greater trochanter (corresponding to a long axis of the thigh), while a movable arm at lateral ankle (along shanks).
Measurements of the muscle strength (according to the Lovett scale) were taken symmetrically, firstly on a healthy limb in the position depending on the group of muscles involved in the study. Testing of flexors was performed in the standing position, with the anterior body surface adhering to the wall and stabilized pelvis, with a non-tested limb placed on a rather low platform and a tested limb hanging freely. The assessed movement was tested in the following way: 3 according to the Lovett scale – free knee flexing, 4 according to the Lovett scale – flexing with submaximal resistance applied above tuber calcanei, 5 according to the Lovett scale – flexing the maximal resistance applied as in test 4. Testing of extensors was performed in the sitting position with lower legs hanging freely, with no support for the feet. The untested limb was placed in the position of abduction in the hip joint to the angle of 30. Patients were asked to auto-stabilize themselves by gripping the edge of the couch and the anterior aspect of the thigh of the tested limb was stabilized. The assessed movement was tested in the following manner: 3 according to the Lovett scale – knee extension perpendicularly to the floor, 4 according to the Lovett scale – knee extension with submaximal resistance applied above ankles on the anterior aspect of a lower leg, 5 according to the Lovett scale – knee extension with maximal resistance applied as in test 4.
KOOS (Knee Injury and Osteoarthritis Outcome Score) and SF-36 (The Short Form (36) Health Survey) were used in the study.
The study group subjects were free to express their subjective, short, written opinion about the therapy using the BodyFlow device for mild electrostimulation.
A difference in specific measures of the knee after arthroscopy was used to analyze size, range of motion, and muscle strength. To analyze the KOOS and SF-36 survey scores, the differences in percentage results for specific elements assessing physical and mental functioning were considered. A mean and standard deviation were calculated for each group of assessed parameters. The t-student test was performed for independent groups, calculating statistical significance between the study and control group. A significance ratio 0.05 was applied in each test.
Results
Out of 93 subjects included in the study, 6 could not be assessed on day 21 after intervention. Three study group patients did not perform mild electrostimulation, while 3 control group patients refused to participate in the study. Moreover, 10 patients, including 3 from the study group and 6 from the control group, were unavailable after 9 weeks (Fig. 1).
Characteristics of the participants ( 93)
Characteristics
SG ( 51)
CG ( 42)
Sex (males), (%)
43 (84)
23 (55)
Age (years), mean (SD)
34 (12)
32 (10)
Kind of arthroscopy
Meniscectomy
14 (27)
17 (40)
ACL reconstruction, n(%)
37 (73)
25 (60)
SG – study group, CG – control group.
The characteristics of the participants from each group are shown in Table 1 and in the two first columns in Tables 2–4.
Group differences (standard deviation) in the measurements of size, range of motion, and muscle strength on specific study days
Results
Groups
Group differences
Significance
Day 0
Day 21
Day 63
Day 21
Day 63
Day 21
Day 63
SG ( 51)
CG ( 42)
SG ( 48)
CG ( 39)
SG ( 45)
CG ( 33)
SG
CG
SG
CG
Size (cm)
U1
0.70
(1.29)
1.44 (1.72)
0.60 (0.92)
1.44 (1.64)
0.40 (0.72)
1.05 (1.22)
0.12 (0.76)
0.01 (0.85)
0.35 (1.07)
0.34 (0.98)
0.5
0.5
U2
0.21 (1.93)
0.48 (2.07)
0.79 (1.08)
0.49 (1.98)
0.60 (0.90)
0.57 (1.60)
0.51 (1.76)
0.15 (0.97)
0.32 (1.81)
0.18 (0.83)
0.2
0.5
K
2.76 (1.12)
2.61 (1.36)
1.04 (0.77)
1.82 (0.93)
0.58 (0.49)
1.52 (0.91)
1.76 (1.21)
0.74 (0.83)
2.28 (1.14)
1.07 (1.02)
0.001
0.001
G1
0.38 (1.42)
0.15 (1.44)
0.41 (0.76)
0.29 (1.07)
0.36 (0.68)
0.21 (0.86)
0 (1.13)
0.14 (1.05)
0.03 (1.08)
0.04 (1.06)
0.5
0.5
Range
of
Flexion
64.88 (25.02)
61.76 (23.45)
23.97 (19.13)
35.73 (20.52)
11.78 (11.77)
19.52 (10.75)
41.54 (16.59)
25.31 (16.03)
56.14 (17.64)
39.52 (18.60)
0.001
0.001
motion
Extension
5.63 (6.57)
3.69 (4.81)
0.95 (2.11)
2.38 (4.12)
0.47 (1.30)
1.71 (3.27)
3.90 (5.24)
1.13 (1.82)
4.80 (5.80)
1.93 (2.69)
0.002
0.005
Muscle strength
Flexors
1.46 (0.37)
1.70 (0.40)
0.70 (0.40)
1.16 (0.40)
0.31 (0.34)
0.83 (0.31)
0.77 (0.38)
0.51 (0.35)
1.10 (0.50)
0.80 (0.46)
0.001
0.005
(Lovett)
Extensors
1.48 (0.38)
1.62 (0.43)
0.60 (0.40)
1.03 (0.38)
0.26 (0.35)
0.71 (0.35)
0.80 (0.46)
0.60 (0.34)
1.20 (0.50)
0.90 (0.47)
0.02
0.005
SG – study group, CG – control group.
The study group scores were better than those obtained in the control group. After 3 weeks, t-student test for independent groups demonstrated a statistically significant difference for the knee joint size, range of motion and strength of the knee flexors and extensors (Table 2). Given the KOOS complete scores, a statistically significant difference was observed in all categories under analysis (Table 3), while in the SF-36 survey the differences concerned physical functioning, physical role functioning, and the total scores concerning physical functions (Table 4). Nine weeks after arthroscopy, statistically significant differences in the categories mentioned above were still observed and statistically significant differences in the SF-36 survey scores were observed. They included pain subscales, general health perception, vitality, social and emotional role functioning (Table 4). All opinions expressed by the study group subjects on the therapy using the BodyFlow device were positive.
Group differences (standard deviation) in the KOOS scores on specific study days
Results
Groups
Group differences
Significance
Day 0
Day 21
Day 63
Day 21/Day 0
Day 63/Day 0
Day 21/
Day 63/
SG ( 51)
CG ( 42)
SG ( 48)
CG ( 39)
SG ( 45)
CG ( 33)
SG
CG
SG
CG
Day 0
Day 0
Symptoms
and
stiffness
34.86 (16.26)
48.95 (15.46)
56.87 (20.42)
58.11 (13.19)
73.21 (18.18)
65.99 (15.78)
22.25 (16.99)
9.45 (12.40)
37.99 (21.31)
17.01 (18.34)
0.001
0.001
Pain
43.92 (19.29)
52.78 (17.78)
66.60 (18.54)
63.08 (14.92)
79.24 (15.47)
71.23 (15.98)
21.51 (14.23)
10.53 (17.15)
34.26 (20.27)
18.98 (17.27)
0.001
0.001
Everyday
activities
41.67 (19.77)
52.54 (17.70)
69.65 (19.33)
72.28 (14.97)
87.17 (14.86)
82.28 (13.28)
26.89 (12.56)
19.83 (16.13)
44.53 (19.66)
28.96 (17.38)
0.02
0.001
Sport and
recreational
activity
4.29 (8.87)
6.57 (17.62)
21.93 (19.25)
15.52 (23.57)
43.06 (25.93)
23.33 (27.82)
17.82 (17.50)
9.17 (21.37)
39.03 (23.08)
16.19 (21.58)
0.05
0.001
Life quality
21.88 (15.87)
25.98 (16.60)
40.06 (19.11)
33.33 (15.70)
54.34 (20.09)
41.07 (17.03)
18.27 (12.37)
7.29 (17.31)
33.33 (18.60)
14.88 (14.47)
0.001
0.001
KOOS
score
34.81 (14.73)
44.06 (13.35)
58.40 (16.80)
57.47 (12.37)
74.80 (14.70)
66.30 (13.89)
23.01 (11.42)
13.56 (14.04)
39.40 (16.80)
21.93 (15.04)
0.1
0.002
SG – study group, CG – control group.
Group differences (standard deviation) of the SF-36 scores on specific study days
Results
Groups
Group differences
Significance
Day 0
Day 21
Day 63
Day 21 /Day 0
Day 63 /Day 0
Day 21/
Day 63/
SG ( 51)
CG ( 42)
SG ( 48)
CG ( 39)
SG ( 45)
CG ( 33)
SG
CG
SG
CG
Day 0
Day 0
SF-36 Norm-
Physical
functioning
25.15 (8.25)
27.64 (8.73)
36.03 (10.57)
34.01 (9.87)
44.81 (8.78)
41.10 (8.23)
10.92 (8.33)
6.39 (8.10)
19.99 (8.93)
12.60 (8.15)
0.01
0.05
based scales score
Physical
role
functioning
32.51 (6.75)
34.48 (8.08)
37.74 (9.39)
36.21 (8.65)
43.07 (10.83)
38.23 (9.63)
4.88 (8.89)
1.47 (6.34)
9.99 (11.24)
3.20 (7.50)
0.05
0.001
Bodily
pain
30.28 (9.30)
32.02 (8.79)
36.69 (10.84)
36.21 (8.82)
43.20 (10.60)
40.22 (8.41)
5.98 (7.25)
3.72 (7.71)
12.59 (10.97)
6.60 (7.39)
0.2
0.005
General
health
perception
38.94 (5.70)
40.07 (5.61)
41.12 (5.08)
40.17 (5.60)
43.64 (4.78)
41.77 (6.26)
2.00 (5.84)
0.22 (4.20)
4.01 (5.55)
1.69 (4.93)
0.1
0.05
Vitality
44.95 (8.00)
46.75 (9.79)
48.88 (7.57)
46.50 (8.89)
52.81 (7.26)
48.17 (9.11)
3.58 (7.34)
4.44 (10.24)
7.76 (8.71)
1.48 (9.37)
0.5
0.001
Social
role
functioning
33.88 (11.46)
37.13 (12.44)
39.47 (9.70)
39.73 (11.68)
46.44 (7.49)
43.57 (8.98)
4.87 (9.04)
3.29 (8.29)
11.31 (12.33)
5.04 (9.54)
0.5
0.01
Emotional
role
functioning
33.50 (12.61)
41.89 (13.33)
38.58 (12.24)
44.34 (13.20)
43.62 (13.01)
45.78 (12.90)
4.33 (12.02)
2.19 (9.94)
8.78 (14.79)
2.75 (10.15)
0.5
0.05
Mental
health
41.68 (10.72)
42.70 (9.96)
43.48 (8.90)
43.20 (7.59)
46.59 (6.80)
45.51 (6.89)
1.01 (8.83)
0.70 (9.62)
8.78 (14.79)
2.31 (9.74)
0.5
0.5
SF36
summary
scores
Physical
complete
score
26.46 (6.21)
27.40 (7.90)
34.32 (8.60)
31.57 (7.78)
41.54 (8.35)
36.42 (8.83)
7.87 (6.91)
3.98 (6.87)
15.26 (8.03)
8.26 (7.16)
0.01
0.001
Mental
complete
score
44.21 (10.21)
48.47 (10.98)
46.21 (6.61)
48.24 (9.00)
47.32 (10.28)
49.03 (8.67)
1.12 (7.69)
0.07 (7.54)
1.63 (10.74)
0.10 (8.52)
0.5
0.5
SG – study group, CG – control group.
Discussion
Mild electrostimulation using the BodyFlow device was applied as an additional therapy in patients after knee arthroscopy to improve primarily physical functions of the operated region and, consequently, improve psychological functions of the subject. It stimulates the flow of fluids through the operated region, enhances drainage, and supports faster regeneration. These changes are a result of the activation of the smooth muscles of lymphatic and blood vessels by the appropriately adjusted stimulation currents. Moreover, patients under therapy may feel contractions of transverse striated muscles, which contributes to a better functioning of the limb muscle pump after treatment.
Application of the therapy after joint arthroscopy, recommended by the authors, i.e. intervention using the BodyFlow Portable P2CH device, demonstrated a wide range of benefits. The study demonstrated a positive, statistically significant difference between the study group subjects performing mild electrostimulation and control group subjects with regard to the knee size, range of motion of the knee (flexion and extension), strength of knee extensors and flexors, and specific categories included in the KOOS and SF-36 surveys. After 3 weeks of the therapy, a significant difference in symptoms, stiffness, pain, everyday activities, sporting and recreational activity, life quality covered by the KOOS survey as well as physical functioning, physical role functioning and general scoring of physical functions included in the SF-36 survey was observed. After 48 days, more positive, statistically significant changes covered by the SF-36 survey were revealed. They regarded psychological role functioning, pain subscales, general health perception, vitality, social and emotional role functioning, with other parameters at the same level as on study day 21. Improvement in physical functions results from the improved knee functionality after arthroscopy as a patient’s physical and mental state impacts the course and efficacy of the postoperative treatment 6 and vice versa.
The results of this study may not be compared with other studies assessing the impact of mild electrostimulation using the BodyFlow device after knee arthroscopy as they are unavailable or not published in peer-reviewed journals. Given the available publications on the application of the BodyFlow device, it is possible to confirm its efficacy regarding acceleration of blood flow, fibrinolysis and activation of anticoagulant factors [16], regeneration in sport [17], reduction of lymphatic swellings [18] as well as improved healing of wounds [19].
The general recommendation is that mild electrostimulation should be performed 4–6 times a day. The subjects performed the treatment 5 times a day, every 3 hours. The therapy lasted 3 weeks, which is the same as the average series of treatments applied to patients after knee arthroscopy.
The first clinical study on the therapy using the BodyFlow device was published in 2007 and revealed its impact on the acceleration of blood flow, fibrinolysis, and activation of anticoagulant factors. The study involved 23 healthy volunteers and measurements were taken 2 and 6 hours after therapy [16]. Another clinical study involved 16 patients, lasted 56 days, and included 8 therapeutic sessions. The findings proved the impact of mild electrostimulation on acceleration of regeneration in healthy subjects after micro-injuries but suggested the need for further studies due to ambiguous mechanisms of operation [17].
Another study on the effect of mild electrostimulation using the BodyFlow device on lymphatic swellings involved 41 patients in three groups, lasted a month and included 13 therapeutic sessions. The findings proved a positive impact and better effects than any anti-swelling therapy performed individually in the best possible manner [18].
A recent publication discussed three casuistic cases where therapy yielded good effects regarding the healing of wounds caused by the lower leg ulceration due to venous insufficiency [19].
In comparison to previous conducted studies, this study involved the largest group of patients. As the therapy using the BodyFlow device is safe, i.e. no side effects were observed in the previous studies, as well as nice and convenient for patients (a portable device, treatments performed independently, at home) and has a positive impact on functionality and mental state of patients, it would be a good idea to introduce it into the already adopted standards of the procedure after knee arthroscopy [16, 17, 18, 19].
Conclusion
Mild electrostimulation therapy using the BodyFlow device is an innovative therapy. The number of available studies and scientific publications on this subject is small. Those that have been published demonstrate a positive effect of mild electrostimulation therapy on the subjects. Yet the efficacy of the therapy after knee arthroscopy is still unknown.
In our study we showed that mild electrostimulation treatments using the BodyFlow Portable P2CH device in patients after knee arthroscopy have a positive impact on the swelling in the knee region, range of motion, strength of extensors and flexors as well as physical, psychological, and social functioning.
Footnotes
Acknowledgments
University of Lodz Grant No. 502-03/7-048-01/502-54-118.
Conflict of interest
None to report.
References
1.
MayrHOStoehrA. Complications of knee arthroscopy. Orthopade.2015; 132: 1431-1433.
2.
ThorlundJBJuhlCBRoosEMLohmanderLS. Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms. Br J Sports Med.2015; 49(19): 1229-1235.
3.
VaishyaRAgarwalAKIngoleSVijayV. Current trends in anterior cruciate ligament reconstruction: A Review. Cureus.2015; 7(11): e378.
4.
FilhoESIsolaniGRBarachoFRde Oliveira FrancoAPRidder BauerLANambaM. Pseudoaneurysm after arthroscopic procedure in the knee. Rev Bras Ortop.2015; 50(2): 131-135.
5.
RosselandLASolheimNStubhaugA. Pain and disability 1 year after knee arthroscopic procedures. Acta Anaesthesiol Scand.2008; 52(3): 332-337.
6.
FlaniganDCEverhartJSGlassmanAH. Psychological factors affecting rehabilitation and outcomes following elective orthopaedic surgery. J Am Acad Surgery.2015; 23(9): 563-570.
7.
El GhazalySARahmanAAYusryAHFathallaMM. Arthroscopic partial meniscectomy is superior to physical rehabilitation in the management of symptomatic unstable meniscal tear. Int Orthop.2015; 39(4): 769-775.
8.
IthurburnMPPaternoMVFordKRHewettTESchmittLC. Young athletes with quadriceps femoris strength asymmetry at return to sport after anterior cruciate ligament reconstruction demonstrate asymmetric single-leg drop-landing mechanics. Am J Sports Med.2015; 43(11): 2727-2737.
HarrisKDribanJBSitlerMRCattanoNMHootmanJM. Five-year clinical outcomes of a randomized trial of anterior cruciate ligament treatment strategies: an evidence-based practice paper. J Athl Train.2015; 50(1): 110-112.
11.
MalempatiCJurjansJNoehrenBIrelandMLJohnsonDL. Current rehabilitation concepts for anterior cruciate ligament surgery in athletes. Orthopedics.2015; 38(11): 689-696.
12.
TaradajJHalskiTKucharzewskiM, et al. The effect of neuromuscular electrical stimulation on quadriceps strength and knee function in professional soccer players: return to sport after ACL reconstruction. Biomed Res. Int.2013; 2013: 802534.
13.
GlavianoNRSalibaS. Can the use of neuromuscular electrical stimulation be improved to optimize quadriceps strengthening? Sports Health.2015; 18: pii: 1941738115618174.
14.
LepleyLKWojtysEMPalmieri-SmithRM. Combination of eccentric exercise and neuromuscular electrical stimulation to improve biomechanical limb symmetry after anterior cruciate ligament reconstruction. Clin Biomech.2015; 30(7): 738-747.
15.
DemirciogluDTPakerNErbilEBugdayciDEmreTY. The effect of neuromuscular electrical stimulation on functional status and quality of life after knee arthroplasty: a randomized controlled study. J Phys Ther Sci.2015; 27(8): 2501-2506.
16.
ParsiKExnerTConnorDWhittakerSJosephJEMaD. Blood flow, fibrinolysis and anti-procoagulant activity after treatment with a portable electrostimulation device (Bodyfl ow™) in healthy subjects. The Australian College of Phlebology.2007; 21: 1510-1520.
17.
SostaricSPearceAGattBMcKennaMJStathisCGoodmanC. Effects of mild electro-stimulation (Bodyflow) treatment on healthy humans following exercise induced muscle damage. Centre for Ageing, Rehabilitation, Exercise & Sport. Victoria University, 2007.
18.
PillerNDouglassJHeidenreichBMoseleyA. Placebo controlled trial of mild electrical stimulation. J of Lymph.2010; 5(1): 15-25.
19.
MillerCMcGuinessBWoodwardMBooE. Client concordance and wound healing using the BodyFlow™ electrostimulation device: case series. Wound Practice & Research. 22(3): 145-154.